12778 studies found for:    Canada
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: Natalizumab;   Drug: Placebo
2 Completed Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Adalimumab
3 Completed A New Oral Treatment For Type II Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: GW0823093
4 Active, not recruiting Open-label Follow up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Aged 16 Years or Older Suffering From Epilepsy.
Condition: Epilepsy
Intervention: Drug: Brivaracetam
5 Terminated Open-label Trial of Leukine in Active Crohn's Disease
Condition: Crohn Disease
Intervention: Drug: Sargramostim (Leukine)
6 Completed Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
Conditions: Dysmenorrhea;   Dyspareunia;   Endometriosis;   Pelvic Pain
Intervention: Drug: ERB-041
7 Completed Safety Study of Apixaban in Recent Acute Coronary Syndrome
Condition: Acute Coronary Syndrome (ACS)
Interventions: Drug: Apixaban;   Drug: Placebo
8 Completed Temozolomide and Everolimus in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: everolimus;   Drug: temozolomide;   Genetic: microarray analysis;   Other: immunohistochemistry staining method
9 Completed
Has Results
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
Condition: Hyperlipidemia
Interventions: Drug: Rosuvastatin;   Drug: Atorvastatin
10 Completed A Phase I, Single IV Dose Of PF-04360365 In Adults With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: PF-04360365;   Drug: Placebo
11 Completed Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE)
Conditions: Coronary Artery Disease (CAD);   Percutaneous Coronary Intervention (PCI)
Interventions: Drug: M118;   Drug: Unfractionated Heparin
12 Completed
Has Results
Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.
Conditions: Pulmonary Disease, Chronic Obstructive;   Asthma
Intervention: Drug: BI 1744CL
13 Active, not recruiting Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide)
14 Terminated Calfactant for Direct Acute Respiratory Distress Syndrome
Condition: Respiratory Distress Syndrome, Adult
Interventions: Drug: Calfactant;   Drug: Room Air (placebo)
15 Terminated
Has Results
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: UK-432,097;   Drug: Placebo
16 Completed Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
Condition: Chronic Hepatitis C
Interventions: Drug: alb-interferon alfa 2b;   Drug: peg-interferon
17 Recruiting Neuropsychological and Behavioral Testing in Young Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity;   Cognitive/Functional Effects;   Neurotoxicity;   Psychosocial Effects of Cancer and Its Treatment;   Radiation Toxicity;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Other: questionnaire administration;   Procedure: cognitive assessment;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment
18 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
19 Completed Effects of Rosuvastatin on Aortic Stenosis Progression
Condition: Aortic Stenosis
Interventions: Drug: Rosuvastatin;   Drug: Placebo
20 Terminated
Has Results
(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Ambrisentan;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years